EuroEyes International Eye Clinic Limited (HKG:1846)
2.990
-0.020 (-0.66%)
At close: Feb 13, 2026
HKG:1846 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 76.53 | 82.29 | 131.24 | 89.47 | 133.56 | 65.58 |
Depreciation & Amortization | 116.35 | 112.06 | 87.21 | 80.58 | 74.61 | 67.25 |
Other Amortization | 0.15 | 0.15 | 0.14 | 0.14 | 0.05 | 0.09 |
Loss (Gain) From Sale of Assets | 1.08 | 1.08 | 0.38 | -0.21 | 0.29 | -0.18 |
Asset Writedown & Restructuring Costs | 11 | 11 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -0.14 | -0.51 | - |
Stock-Based Compensation | 1.56 | 1.56 | 2.23 | 2.68 | 11.33 | 0.88 |
Other Operating Activities | -21.98 | -22.04 | -32.25 | 25.89 | 22.81 | -15.51 |
Change in Accounts Receivable | 1.42 | 1.42 | 0.95 | 1.98 | 0.91 | -1.36 |
Change in Inventory | -3.32 | -3.32 | 29.56 | 8.23 | 8.04 | 0.63 |
Change in Accounts Payable | 5.62 | 5.62 | -30.61 | -10.22 | 3.76 | -7.69 |
Change in Unearned Revenue | 0.87 | 0.87 | 2.8 | -16.62 | 1.4 | -0.36 |
Change in Other Net Operating Assets | 7.06 | 7.06 | 0.2 | 27.27 | 17 | -30.88 |
Operating Cash Flow | 196.36 | 197.75 | 191.86 | 209.05 | 273.26 | 78.46 |
Operating Cash Flow Growth | -3.07% | 3.07% | -8.22% | -23.50% | 248.29% | 21.79% |
Capital Expenditures | -64.91 | -80.34 | -88.92 | -56.31 | -43.98 | -38.34 |
Sale of Property, Plant & Equipment | 5.41 | 2.62 | - | 0.63 | 0.09 | 0.2 |
Cash Acquisitions | -5.75 | -6.12 | -90.73 | -91.45 | - | - |
Sale (Purchase) of Intangibles | - | - | -0.64 | - | -0.57 | - |
Investment in Securities | - | - | - | 15.32 | -15.44 | - |
Investing Cash Flow | -65.24 | -83.83 | -180.29 | -131.81 | -59.9 | -38.14 |
Long-Term Debt Repaid | - | -73.17 | -59.31 | -63.19 | -44.6 | -50.52 |
Net Debt Issued (Repaid) | -74.47 | -73.17 | -59.31 | -63.19 | -44.6 | -50.52 |
Repurchase of Common Stock | -48.39 | -35.8 | - | -8.36 | -15.28 | -4.35 |
Common Dividends Paid | -21.84 | -27.85 | -39.68 | -33.1 | -9.84 | -62.05 |
Other Financing Activities | - | - | -3.78 | 2.43 | 0.54 | 0.55 |
Financing Cash Flow | -144.7 | -136.82 | -102.76 | -102.22 | -69.18 | -116.37 |
Foreign Exchange Rate Adjustments | 65.81 | -44.09 | 31.84 | -41.09 | -60.37 | 50.86 |
Net Cash Flow | 52.22 | -66.98 | -59.35 | -66.07 | 83.81 | -25.19 |
Free Cash Flow | 131.44 | 117.41 | 102.94 | 152.74 | 229.28 | 40.12 |
Free Cash Flow Growth | 17.23% | 14.06% | -32.61% | -33.38% | 471.51% | 13.78% |
Free Cash Flow Margin | 18.14% | 16.41% | 14.41% | 25.03% | 36.23% | 8.47% |
Free Cash Flow Per Share | 0.41 | 0.36 | 0.31 | 0.46 | 0.70 | 0.11 |
Cash Income Tax Paid | 49.87 | 51.07 | 93.1 | 18.79 | 33.67 | 66.49 |
Levered Free Cash Flow | 113.22 | 71.74 | 91.1 | 175.68 | 198.88 | -32.36 |
Unlevered Free Cash Flow | 119 | 78.01 | 97.16 | 180.12 | 203.56 | -27.99 |
Change in Working Capital | 11.65 | 11.65 | 2.9 | 10.62 | 31.11 | -39.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.